[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576482":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":23,"responsibleParty":44,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":73,"overallStatus":80,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Erythrocytosis patients",null,"Adult patients (\\>=18 years) referred to hematology clinics at London Health Sciences Centre (LHSC) with erythrocytosis or polycythemia with hemoglobin levels \\>=165 g\u002FL in males or \\>=160 g\u002FL in females at the time of initial clinic visit.",[13,19],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Cyrus C. Hsia, MD, FRCPC","CONTACT","1-519-685-8500","56060","cyrus.hsia@lhsc.on.ca",{"name":20,"role":15,"phone":21,"phoneExt":10,"email":22},"Benjamin Chin-Yee, MD, FRCPC","1-519-685-8718","benjamin.chin-yee@lhsc.on.ca",[24],{"facility":25,"status":10,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Victoria Hospital, London Health Sciences Centre","London","Ontario","N6A 5W9","Canada","CA",{"type":32,"coordinates":33},"Point",[34,35],-81.23304,42.98339,{"lat":35,"lon":34},[38,39,40,42],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},{"name":20,"role":15,"phone":21,"phoneExt":10,"email":22},{"name":41,"role":15,"phone":10,"phoneExt":10,"email":10},"Jenny Ho, MD, FRCPC",{"name":43,"role":15,"phone":10,"phoneExt":10,"email":10},"Alejandro Lazo-Langner, MD, FRCPC",{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Cyrus Hsia","Hematologist","100576482","evaluation-of-erythrocytosis-prospective-cohort-study-100576482",false,"NCT06785870","EVAluation of Erythrocytosis PRospEctive Cohort STudy","Evaluation of Erythrocytosis Prospective Cohort Study (EVEREST): Diagnosis, Management and Longitudinal Outcomes in Patients with Elevated Hemoglobin","EVEREST","Inclusion Criteria:\n\n1. Adult patients (\\>=18 years) referred to hematology clinics at London Health Sciences Centre with hemoglobin levels \\>=165 g\u002FL in males or \\>=160 g\u002FL in females.\n2. Patients capable of providing informed consent.\n3. Age \\>= 18 years.\n\nExclusion Criteria:\n\n1. Patients \\\u003C18 years.\n2. Patients without erythrocytosis.\n3. Patients incapable of providing informed consent.","ALL","18 Years",{"count":59,"type":60},1500,"ESTIMATED","5 Years","OBSERVATIONAL","The EValuation of ERythrocytosis pRospEctive cohort STudy (EVEREST) is a prospective study designed to shed light on these key questions in the diagnosis, management, and clinical outcomes in patients with elevated hemoglobin (erythrocytosis). This longitudinal, prospective study will generate high quality data that can help inform the optimal approach to diagnosis and management in this patient population.",[65,66,67,68,69,70,71,72],"Erythrocytosis","Polycythemia","Polycythemia Secondary","Polycythemia Vera","Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase","Polycythemia Vera (PV)","Polycythemia; Familial","Polycythemia, Primary",[74,75,65,66,76,77,78,79],"Prospective","Observational Study","Patient Registry","Diagnosis","Management","Outcomes","NOT_YET_RECRUITING","2025-01-19",{"date":83,"type":84},"2025-01-21","ACTUAL",{"date":86,"type":60},"2025-02-01",{"date":88,"type":60},"2030-12-31",{"name":46,"class":6},1]